F13.14
Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced mood disorder
Clinical Classification Guidelines
Inclusion Terms
- Sedative, hypnotic, or anxiolytic use disorder, mild, with sedative, hypnotic, or anxiolytic-induced bipolar or related disorder
- Sedative, hypnotic, or anxiolytic use disorder, mild, with sedative, hypnotic, or anxiolytic-induced depressive disorder
Medical Intelligence & Overview
ICD-10 code F13.14 describes a condition where a person misuses sedatives, hypnotics, or anxiolytics, leading to mood disturbances such as depression or bipolar-like symptoms. This dual diagnosis signifies both substance abuse and mood disorder symptoms caused or exacerbated by these medications or substances. Recognizing and understanding this condition can help in the development of appropriate treatment strategies, though it is essential to consult healthcare professionals for diagnosis and management.
Causes & Symptoms
Clinical Causes: Prolonged or excessive use of sedatives, hypnotics, or anxiolytics, often prescribed for sleep or anxiety disorders Dependence on medications without medical supervision Self-medication to cope with stress, anxiety, or mood disturbances Lack of adherence to prescribed dosages can lead to abuse Underlying mental health conditions that increase vulnerability to misuse of these substances
Key Symptoms: Altered mood states, including depression or episodes that resemble bipolar disorder Changes in sleep patterns, such as insomnia or hypersomnia Increased tolerance, needing higher doses to achieve the same effect Withdrawal symptoms when not taking the substances, such as anxiety, agitation, or sleep disturbances Impaired judgment or impaired functioning due to substance use and mood fluctuations Behavioral signs like social withdrawal, irritability, or substance-seeking behaviors
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a comprehensive assessment by a healthcare professional, including a detailed history of substance use and mood symptoms. Medical evaluations may include physical examinations, laboratory tests, and psychological assessments. The clinician will identify patterns of sedative, hypnotic, or anxiolytic misuse and associate mood symptoms to establish the dual diagnosis. It's essential to differentiate between primary mood disorders and those induced by substance use.
Treatment Protocols: Effective management often requires a multidimensional approach, including: - Medically supervised detoxification if withdrawal symptoms are present - Psychotherapy, such as cognitive-behavioral therapy (CBT), to address substance use behaviors and underlying mental health issues - Medication-assisted treatment when appropriate, under careful medical supervision - Support groups and counseling to promote recovery and prevent relapse - Ongoing monitoring and support to manage mood symptoms and prevent future misuse Because of the complexity of this condition, treatment plans are tailored to individual needs, emphasizing a safe and sustainable recovery process.
Clinical Advice & FAQs
Billing Guidance
Is F13.14 a billable ICD-10 code?
Yes, F13.14 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F13.14?
Clinical documentation must specify the nature of Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced mood disorder and any associated comorbidities for accurate reporting.
Cite this Clinical Reference